Home

agilon health, inc. Common Stock (AGL)

3.9000
+0.0800 (2.09%)
NYSE · Last Trade: Apr 26th, 9:54 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
1 Safe-and-Steady Stock with Promising Prospects and 2 to Ignore
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.
Via StockStory · April 24, 2025
Russell 2000 Index Forecast As The Crash Continues: Buy The Dip?talkmarkets.com
The Russell 2000 Index has plunged and formed a death cross this year as American stocks sink amid rising worries about Donald Trump’s policies.
Via Talk Markets · April 22, 2025
Outpatient & Specialty Care Stocks Q4 Teardown: Encompass Health (NYSE:EHC) Vs The Rest
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Encompass Health (NYSE:EHC) and its peers.
Via StockStory · April 18, 2025
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.chartmill.com
Looking for insights into the US markets one hour before the close of the markets on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · April 17, 2025
Which stocks are moving on Thursday?chartmill.com
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.
Via Chartmill · April 17, 2025
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · April 17, 2025
There are notable gap-ups and gap-downs in today's session.chartmill.com
Traders are paying attention to the gapping stocks in Thursday's session. Let's dive into which stocks are experiencing notable gaps.
Via Chartmill · April 17, 2025
Outpatient & Specialty Care Stocks Q4 Teardown: Select Medical (NYSE:SEM) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at outpatient & specialty care stocks, starting with Select Medical (NYSE:SEM).
Via StockStory · April 17, 2025
Where Agilon Health Stands With Analystsbenzinga.com
Via Benzinga · April 15, 2025
2 Reasons to Like AGL and 1 to Stay Skeptical
What a fantastic six months it’s been for agilon health. Shares of the company have skyrocketed 65.7%, hitting $5.50. This run-up might have investors contemplating their next move.
Via StockStory · April 15, 2025
These Mid-Cap Stocks Outshone The Market Volatility Last Week (Apr 7-Apr 11): Are These In Your Portfolio?benzinga.com
Top mid-cap stock performers last week: AGL, RXRX, CERT, AVAV, STRL, ORLA, IAG, SBSW, LOAR, RYTM, TLX. High gains due to positive news and macro uncertainty.
Via Benzinga · April 13, 2025
Q4 Earnings Outperformers: DaVita (NYSE:DVA) And The Rest Of The Outpatient & Specialty Care Stocks
Let’s dig into the relative performance of DaVita (NYSE:DVA) and its peers as we unravel the now-completed Q4 outpatient & specialty care earnings season.
Via StockStory · April 10, 2025
Why Is agilon health (AGL) Stock Soaring Today
Shares of healthcare services company Agilon Health (NYSE:AGL) jumped 29.9% in the afternoon session after Bernstein upgraded the stock's rating from Hold to Buy with a price target of $8.5. The firm noted that new data on AGL drove increased confidence in its turnaround plans and cash position.
Via StockStory · April 8, 2025
Which stocks are moving on Tuesday?chartmill.com
Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · April 8, 2025
Which stocks are experiencing notable movement on Tuesday?chartmill.com
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · April 8, 2025
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · April 8, 2025
Traders are paying attention to the gapping stocks in Tuesday's session.chartmill.com
Let's have a look at the gap up and gap down stocks in today's session.
Via Chartmill · April 8, 2025
Medicare Advantage Rates Expected To Climb Over 5% In 2026, Easing Pressure On Managed Carebenzinga.com
CMS raises 2026 Medicare Advantage payments by 5.06%, exceeding projections and benefiting insurers focused on value-based care.
Via Benzinga · April 8, 2025
Marvell Technology, Nvidia, Tesla, Apple And Other Big Stocks Moving Higher On Tuesdaybenzinga.com
Via Benzinga · April 8, 2025
Wondering what's happening in today's after-hours session?chartmill.com
After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · April 7, 2025
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · April 7, 2025
Q4 Earnings Outperformers: AMN Healthcare Services (NYSE:AMN) And The Rest Of The Healthcare Providers & Services Stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare providers & services industry, including AMN Healthcare Services (NYSE:AMN) and its peers.
Via StockStory · April 2, 2025
Q4 Earnings Highs And Lows: agilon health (NYSE:AGL) Vs The Rest Of The Outpatient & Specialty Care Stocks
Let’s dig into the relative performance of agilon health (NYSE:AGL) and its peers as we unravel the now-completed Q4 outpatient & specialty care earnings season.
Via StockStory · April 2, 2025
Q4 Earnings Outperformers: McKesson (NYSE:MCK) And The Rest Of The Healthcare Providers & Services Stocks
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare providers & services stocks, including McKesson (NYSE:MCK) and its peers.
Via StockStory · March 27, 2025
Scholastic Posts Strong Earnings, Joins Ouster, Torrid Holdings, Adaptive Biotechnologies And Other Big Stocks Moving Higher On Fridaybenzinga.com
Via Benzinga · March 21, 2025